%0 Journal Article
%T A Randomized Phase II Study of FOLFOX With or Without the MET Inhibitor Onartuzumab in Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction
%A Alice Kang
%A Chia-Jui Yen
%A David S. Shames
%A Iain B. Tan
%A Jae-Yong Cho
%A Lilian Bu
%A Manish A. Shah
%A Niall C. Tebbutt
%A Yoon-Koo Kang
%J Archive of "The Oncologist".
%D 2016
%R 10.1634/theoncologist.2016-0038
%K MET
%K Gastric cancer
%K Chemotherapy
%K Onartuzumab
%K HER2-negative
%K First line
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016069/